Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Elderly Multiple Myeloma
NCT02302495Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Jan 2014
- Primary completion
- Jul 2016
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM), sponsored by CHU de Lille. Started Jan 2014; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02302495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302495.